ISRCTN57679341已完成不适用
CH-II Langerhans cell histiocytosis: treatment protocol of the second international study
K Co-ordinating Committee for Cancer Research (UKCCCR)0 个研究点目标入组 193 人开始时间: 2001年7月1日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 193
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Definitive diagnosis of Langerhans cell histiocytosis
- •2. Aged under 18 years with involvement of haematopetic system, liver, lungs or spleen or aged under 2 years
- •3. No prior treatment for Langerhans cell histiocytosis
排除标准
- •Does not comply with above criteria
研究者
相似试验
已完成
不适用
angerhans cell histiocytosis (LCH): treatment protocol of the first international studyymphoma (non-Hodgkin's)Langerhans cell histiocytosis (LCH)CancerISRCTN97375227Cancer Research UK (CRUK) (UK)
进行中（未招募）
不适用
Behandling vid Langerhans cellhistiocytos (LCH) - SIM001EUCTR2009-014912-36-SEKarolinska Institutet
已完成
2 期
Treatment of Resistant Langerhans Cell Histiocytosis With ENBRELHistiocytosis, Langerhans-CellNCT00048373Baylor College of Medicine20
招募中
2 期
A Combination of Vemurafenib, Cytarabine and 2-chlorodeoxyadenosine in Children With LCH and BRAF V600E MutationLangerhans Cell HistiocytosisNCT03585686Federal Research Institute of Pediatric Hematology, Oncology and Immunology12
招募中
2 期
Targeted Approach to Langerhans Cell Histiocytosis (LCH) Using MEK Inhibitor, TrametinibLangerhans Cell HistiocytosisNCT06582745Cook Children's Health Care System75